These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20803331)

  • 41. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization.
    Obochi MO; Canaan AJ; Jain AK; Richter AM; Levy JG
    Photochem Photobiol; 1995 Jul; 62(1):169-75. PubMed ID: 7638262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
    Weston MA; Patterson MS
    Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.
    Schmidt-Erfurth U; Bauman W; Gragoudas E; Flotte TJ; Michaud NA; Birngruber R; Hasan T
    Ophthalmology; 1994 Jan; 101(1):89-99. PubMed ID: 8302569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodynamic therapy (PDT) of the ciliary body with silicon naphthalocyanine (SINc) in rabbits.
    Hill RA; Garrett J; Reddi S; Esterowitz T; Liaw LH; Ryan J; Shirk J; Kenney M; Shimuzu S; Berns MW
    Lasers Surg Med; 1996; 18(1):86-91. PubMed ID: 8850470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental photodynamic laser therapy for rheumatoid arthritis with a second generation photosensitizer.
    Hendrich C; Hüttmann G; Vispo-Seara JL; Houserek S; Siebert WE
    Knee Surg Sports Traumatol Arthrosc; 2000; 8(3):190-4. PubMed ID: 10883433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular effects of photodynamic and pulsed dye laser therapy protocols.
    Channual J; Choi B; Osann K; Pattanachinda D; Lotfi J; Kelly KM
    Lasers Surg Med; 2008 Nov; 40(9):644-50. PubMed ID: 18951421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [History of photodynamic therapy--past, present and future].
    Kato H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin.
    van Geel IP; Oppelaar H; Oussoren YG; van der Valk MA; Stewart FA
    Int J Cancer; 1995 Jan; 60(3):388-94. PubMed ID: 7829249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers.
    Hammer-Wilson MJ; Akian L; Espinoza J; Kimel S; Berns MW
    J Photochem Photobiol B; 1999; 53(1-3):44-52. PubMed ID: 10672528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photoproducts of the Photodynamic Therapy Agent Verteporfin Identified via Laser Interfaced Mass Spectrometry.
    Furlan C; Berenbeim JA; Dessent CEH
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
    Busetti A; Soncin M; Jori G; Rodgers MA
    Br J Cancer; 1999 Feb; 79(5-6):821-4. PubMed ID: 10070875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.
    Khurana M; Collins HA; Karotki A; Anderson HL; Cramb DT; Wilson BC
    Photochem Photobiol; 2007; 83(6):1441-8. PubMed ID: 18028219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
    James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative.
    Marcus J; Glassberg E; Dimino-Emme L; Yamamoto R; Moy RL; Vari SG; Papaioannou T; Pergadia VR; Snyder WJ; Grundfest WS
    J Dermatol Surg Oncol; 1994 Jun; 20(6):375-82. PubMed ID: 8014262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer.
    Zeng H; Korbelik M; McLean DI; MacAulay C; Lui H
    Photochem Photobiol; 2002 Apr; 75(4):398-405. PubMed ID: 12003130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
    Korbelik M; Krosl G; Krosl J; Dougherty GJ
    Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photosensitizers in photodynamic therapy.
    Levy JG
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):4-10. PubMed ID: 7992105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
    Sheng T; Ong YH; Guo W; Zhu T
    J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using white light during photodynamic therapy: visualization only or treatment?
    Mordon S; Maunoury V
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):765-71. PubMed ID: 16772834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.